Cargando…

Discovery of a Necroptosis Inhibitor Improving Dopaminergic Neuronal Loss after MPTP Exposure in Mice

Parkinson’s disease (PD) is the second most common neurodegenerative disorder, mainly characterized by motor deficits correlated with progressive dopaminergic neuronal loss in the substantia nigra pars compacta (SN). Necroptosis is a caspase-independent form of regulated cell death mediated by the c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oliveira, Sara R., Dionísio, Pedro A., Gaspar, Maria M., Ferreira, Maria B. T., Rodrigues, Catarina A. B., Pereira, Rita G., Estevão, Mónica S., Perry, Maria J., Moreira, Rui, Afonso, Carlos A. M., Amaral, Joana D., Rodrigues, Cecília M. P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157267/ https://www.ncbi.nlm.nih.gov/pubmed/34069782 http://dx.doi.org/10.3390/ijms22105289

Ejemplares similares

Phenotypic screening identifies a new oxazolone inhibitor of necroptosis and neuroinflammation
por: Oliveira, Sara R., et al.
Publicado: (2018)

Activation of necroptosis in human and experimental cholestasis
por: Afonso, Marta B, et al.
Publicado: (2016)

Ablation of RIP3 protects from dopaminergic neurodegeneration in experimental Parkinson’s disease
por: Dionísio, Pedro A., et al.
Publicado: (2019)

Necroptosis Interfaces with MOMP and the MPTP in Mediating Cell Death
por: Karch, Jason, et al.
Publicado: (2015)

Mechanism and disease implications of necroptosis and neuronal inflammation
por: Oliveira, Sara R., et al.
Publicado: (2018)

Depletion of microglia augments the dopaminergic neurotoxicity of MPTP
por: Yang, Xiaoxia, et al.
Publicado: (2018)

Phenotypic high-throughput screening platform identifies novel chemotypes for necroptosis inhibition
por: Brito, Hugo, et al.
Publicado: (2020)

Lactoferrin ameliorates dopaminergic neurodegeneration and motor deficits in MPTP-treated mice
por: Xu, Shuang-Feng, et al.
Publicado: (2018)

Oncofertility in pediatric patients: current perspectives
por: Marques, Rafael, et al.
Publicado: (2022)

TRH Analog, Taltirelin Protects Dopaminergic Neurons From Neurotoxicity of MPTP and Rotenone
por: Zheng, Cong, et al.
Publicado: (2018)

Synuclein Proteins in MPTP-Induced Death of Substantia Nigra Pars Compacta Dopaminergic Neurons
por: Goloborshcheva, Valeria V., et al.
Publicado: (2022)

miR-335 Targets LRRK2 and Mitigates Inflammation in Parkinson’s Disease
por: Oliveira, Sara R., et al.
Publicado: (2021)

The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration
por: Drouin-Ouellet, Janelle, et al.
Publicado: (2011)

Peripheral Inflammation Enhances Microglia Response and Nigral Dopaminergic Cell Death in an in vivo MPTP Model of Parkinson’s Disease
por: García-Domínguez, Irene, et al.
Publicado: (2018)

Angiotensin type 1 receptor antagonist losartan, reduces MPTP-induced degeneration of dopaminergic neurons in substantia nigra
por: Grammatopoulos, Tom N, et al.
Publicado: (2007)

How to Treat Melanoma? The Current Status of Innovative Nanotechnological Strategies and the Role of Minimally Invasive Approaches like PTT and PDT
por: Lopes, Joana, et al.
Publicado: (2022)

Melanoma Management: From Epidemiology to Treatment and Latest Advances
por: Lopes, Joana, et al.
Publicado: (2022)

Iron Chelators and Antioxidants Regenerate Neuritic Tree and Nigrostriatal Fibers of MPP+/MPTP-Lesioned Dopaminergic Neurons
por: Aguirre, Pabla, et al.
Publicado: (2015)

Sigma-1 receptor deficiency reduces MPTP-induced parkinsonism and death of dopaminergic neurons
por: Hong, J, et al.
Publicado: (2015)

Smilagenin Protects Dopaminergic Neurons in Chronic MPTP/Probenecid—Lesioned Parkinson’s Disease Models
por: He, Xuan, et al.
Publicado: (2019)

Interleukin-4 Protects Dopaminergic Neurons In vitro but Is Dispensable for MPTP-Induced Neurodegeneration In vivo
por: Hühner, Laura, et al.
Publicado: (2017)

Antibiotic-induced microbiome depletion protects against MPTP-induced dopaminergic neurotoxicity in the brain
por: Pu, Yaoyu, et al.
Publicado: (2019)

Chronic Levodopa Administration Followed by a Washout Period Increased Number and Induced Phenotypic Changes in Striatal Dopaminergic Cells in MPTP-Monkeys
por: DiCaudo, Carla, et al.
Publicado: (2012)

Survival of Dopaminergic Amacrine Cells after Near-Infrared Light Treatment in MPTP-Treated Mice
por: Peoples, Cassandra, et al.
Publicado: (2012)

Inhibitory effect of thiacremonone on MPTP-induced dopaminergic neurodegeneration through inhibition of p38 activation
por: Hwang, Chul Ju, et al.
Publicado: (2016)

Herbal medicine (Hepad) prevents dopaminergic neuronal death in the rat MPTP model of Parkinson’s disease
por: Kim, Dong Hee, et al.
Publicado: (2019)

Batryticatus Bombyx Protects Dopaminergic Neurons against MPTP-Induced Neurotoxicity by Inhibiting Oxidative Damage
por: Lim, Hye-Sun, et al.
Publicado: (2019)

Role of RIPK3-CaMKII-mPTP signaling pathway-mediated necroptosis in cardiovascular diseases (Review)
por: Chen, Sheng, et al.
Publicado: (2023)

Necrosis, apoptosis, necroptosis, three modes of action of dopaminergic neuron neurotoxins
por: Callizot, Noëlle, et al.
Publicado: (2019)

Photobiomodulation preserves behaviour and midbrain dopaminergic cells from MPTP toxicity: evidence from two mouse strains
por: Moro, Cécile, et al.
Publicado: (2013)

Discovery of a new mitochondria permeability transition pore (mPTP) inhibitor based on gallic acid
por: Teixeira, José, et al.
Publicado: (2018)

Impact of intravenous immunoglobulin on the dopaminergic system and immune response in the acute MPTP mouse model of Parkinson’s disease
por: St-Amour, Isabelle, et al.
Publicado: (2012)

MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration
por: Lee, Eunju, et al.
Publicado: (2018)

Cerebroventricular Microinjections of MPTP on Adult Zebrafish Induces Dopaminergic Neuronal Death, Mitochondrial Fragmentation, and Sensorimotor Impairments
por: Kalyn, Michael, et al.
Publicado: (2021)

Quercetin Protects against MPP(+)/MPTP-Induced Dopaminergic Neuron Death in Parkinson's Disease by Inhibiting Ferroptosis
por: Lin, Zhi-Hao, et al.
Publicado: (2022)

Ukgansan Protects Dopaminergic Neurons against MPTP-Induced Neurotoxicity via the Nurr1 Signaling Pathway
por: Chae, In-Cheol, et al.
Publicado: (2022)

A dopaminergic deficit hypothesis of schizophrenia: the path to discovery
por: Carlsson, Arvid, et al.
Publicado: (2006)

Assessment of the Effects of MPTP and Paraquat on Dopaminergic Neurons and Microglia in the Substantia Nigra Pars Compacta of C57BL/6 Mice
por: Smeyne, Richard Jay, et al.
Publicado: (2016)

miR-425 deficiency promotes necroptosis and dopaminergic neurodegeneration in Parkinson’s disease
por: Hu, Yong-Bo, et al.
Publicado: (2019)

Neuroprotective Effects of β-Caryophyllene against Dopaminergic Neuron Injury in a Murine Model of Parkinson’s Disease Induced by MPTP
por: Viveros-Paredes, Juan M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ea55vt57l8le21ehbrp2vt0ab1